The U.S. Food and Drug Administration today approved Vizamyl (flutemetamol F 18 injection), a radioactive diagnostic drug for use with positron emission tomography (PET) imaging of the brain in adults being evaluated for Alzheimer's disease (AD) and dementia.  The agent was developed for GE Healthcare by Medi-Physics Inc.

A panel of 15 medical experts from the fields of radiology, obstetrics-gynecology and emergency medicine, convened by the Society of Radiologists in Ultrasound (SRU), has recommended new criteria for use of ultrasonography in determining when a first trimester pregnancy is nonviable (has no chance of progressing and resulting in a live-born baby). These new diagnostic thresholds, published Oct. 10 in the New England Journal of Medicine, would help to avoid the possibility of physicians causing inadvertent harm to a potentially normal pregnancy.
NEJM Exposes Overuse of Radiation Therapy Services When Urologists Profit Through Self-Referral

 A comprehensive review of Medicare claims for more than 45,000 patients from 2005 through 2010 found that nearly all of the 146 percent increase in intensity-modulated radiation therapy (IMRT) for prostate cancer among urologists with an ownership interest in the treatment was due to self-referral. This new research was published in the The New England Journal of Medicine (NEJM) Oct. 24, 2013 issue. However, one association of urologists says the data is flawed.
cardiac ultrasound systems trans esophageal TEE american society echocardiograph

Medical experts released “Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination: Recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists.”

AirStrip announced new research demonstrating the results of its mobility solution AirStrip One Cardiology, along with successful use cases by Rockdale Medical Center, Palomar Health, Montefiore Medical Center and Sequoia Hospital.

Large Urology Group Practice Association (LUGPA), an organization advocating for integrated and coordinated urological care, says it has reviewed the article "Urologists' Use of Intensity-Modulated Radiation Therapy for Prostate Cancer" (Mitchell, JM, New England Journal of Medicine 369:17, Oct. 24, 2013) and found it to be methodologically flawed and factually inaccurate.

Calgary Scientific Inc. announced that in partnership with Siemens Healthcare, they have begun rolling out ResolutionMD at Intermountain Healthcare in Salt Lake City, Utah.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now